|
|
|
|
LEADER |
00000nam a22000004a 4500 |
001 |
5528903 |
003 |
ICU |
005 |
20050810123300.0 |
008 |
040508s2005 njua b 001 0 eng |
010 |
|
|
|a 2004010875
|
016 |
7 |
|
|a 101216499
|2 DNLM
|
020 |
|
|
|a 1588292134 (alk. paper)
|
020 |
|
|
|a 1592597858 (e-isbn)
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d YDX
|d NLM
|d CGU
|d UtOrBLW
|d OrLoB-B
|
042 |
|
|
|a pcc
|
049 |
|
|
|a CGUA
|
050 |
0 |
0 |
|a RC271.G45
|b C355 2005
|
060 |
0 |
0 |
|a 2004 L-762
|
060 |
1 |
0 |
|a QZ 266
|b C21433 2005
|
082 |
0 |
0 |
|a 616.99/40694
|2 22
|
245 |
0 |
0 |
|a Cancer gene therapy /
|c edited by David T. Curiel, Joanne T. Douglas.
|
260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2005.
|
300 |
|
|
|a xii, 489 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Contemporary cancer research
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t Cancer gene therapy : historical perspective /
|r Malcolm K. Brenner --
|g 2.
|t The genetic basis of cancer /
|r Akseli Hemminki and Kari Hemminki --
|g 3.
|t Tumor suppressor gene replacement for cancer /
|r Jack A. Roth and Susan F. Grammer --
|g 4.
|t Antisense technology /
|r Ruiwen Zhang and Hui Wang --
|g 5.
|t Cancer therapeutic applications of ribozymes and RNAi /
|r Lisa Scherer and John J. Rossi --
|g 6.
|t Fusogeneic membrane glycoproteins for cancer gene therapy : a better class of killer /
|r Andrew Bateman, Vy Phan, Alan Melcher, Emmanouela Linardakis, Kevin Harrington and Richard Vile --
|g 7.
|t Suicide gene therapy /
|r Caroline J. Springer and Ion Niculescu-Duvaz --
|g 8.
|t Molecular chemotherapy approaches /
|r Daniel H. Palmer and David J. Kerr --
|g 9.
|t Genetic immunotherapy approaches /
|r Denise R. Shaw and Albert F. LoBuglio --
|g 10.
|t Immunotherapy of cancer by dendritic cell-targeted gene transfer /
|r Tanja D. de Gruijl, Herbert M. Pinedo and Rik J. Scheper --
|g 11.
|t Dendritic cells /
|r Weiping Zou, Shuang Wei and Tyler J. Curiel --
|g 12.
|t Polynucleotide immunization for cancer therapy /
|r Theresa V. Strong --
|g 13.
|t Development of oncolytic replication-competent herpes simplex virus vectors : the G207 paradigm /
|r Tomoki Todo and Samuel D. Rabkin --
|g 14.
|t Development of oncolytic adenoviruses : from the lab bench to the bedside /
|r John A. Howe, Robert Ralston and Murali Ramachandra --
|g 15.
|t Conditionally replicating adenoviruses for cancer treatment /
|r Ramon Alemany --
|g 16.
|t Reovirus as an oncolytic agent /
|r Megan K. Patrick, Kara L. Norman and Patrick W. K. Lee --
|g 17.
|t Antiangiogenic gene therapy of cancer /
|r Steve Gyorffy, Jack Gauldie, A. Keith Stewart and Xiao-Yan Wen --
|g 18.
|t Proapoptotic strategy in cancer gene therapy /
|r David H. Holman, Marc L. Hyer, Ahmed El-Zawahry, Gina M. Keller and James S. Norris --
|g 19.
|t Antimetastasis /
|r Duen-Hwa Yan, Kung-Ming Rau and Mien-Chie Hung --
|g 20.
|t Antimetastatic gene therapy : prostate cancer theory to therapy /
|r Thomas A. Gardner, Juan Antonio Jimenez, Leland W. K. Chung and Chinghai Kao --
|g 21.
|t Drug resistance gene transfer as an antitumor strategy /
|r Colin L. Sweeney and R. Scott McIvor --
|g 22.
|t Chemosensitization /
|r Per Eystein Lonning --
|g 23.
|t Radiosensitizaton by gene theraphy /
|r Steven J. Chmura, Michael Garofalo and Ralph R. Weichselbaum --
|g 24.
|t Nonviral vector systems for cancer gene therapy /
|r Greg F. Walker and Ernst Wagner --
|g 25.
|t Viral vectors for cancer gene therapy /
|r Joanne T. Douglas and David T. Curiel --
|g 26.
|t Bacterial systems for tumor-specific gene therapy /
|r J. Martin Brown, Shie-Chau Liu, Jan Theys and Philippe Lambin --
|g 27.
|t Molecular imaging of cancer gene therapy /
|r Harvey R. Herschman --
|g 28.
|t Cancer-related gene therapy clinical trials /
|r Robert J. Korst and Ronald G. Crystal --
|g 29.
|t Regulatory aspects in the development of gene therapies /
|r Rosemarie Aurigemma, Joseph E. Tomaszewski, Sheryl Ruppel, Stephen Creekmore and Edward A. Sausville.
|
650 |
|
0 |
|a Cancer
|x Gene therapy.
|0 http://id.loc.gov/authorities/subjects/sh92005201
|
650 |
1 |
2 |
|a Gene Therapy.
|
650 |
1 |
2 |
|a Neoplasms
|x therapy.
|
650 |
|
7 |
|a Cancer
|x Gene therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845367
|
700 |
1 |
|
|a Curiel, David.
|0 http://id.loc.gov/authorities/names/n97802979
|1 http://viaf.org/viaf/21434052
|
700 |
1 |
|
|a Douglas, Joanne T.
|0 http://id.loc.gov/authorities/names/n2002013502
|1 http://viaf.org/viaf/48582102
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
035 |
|
|
|a (OCoLC)55138530
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 0231e761-7ac5-5afa-8f0d-3910d7d365e8
|s 4d8d94be-c96f-5d8b-8057-da1814c9fcde
|
928 |
|
|
|t Library of Congress classification
|a RC271.G45C355 2005
|l JCL
|c JCL-Sci
|i 6497726
|
927 |
|
|
|t Library of Congress classification
|a RC271.G45C355 2005
|l JCL
|c JCL-Sci
|e CRERAR
|b 64567015
|i 7778462
|